PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-?-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY
dc.contributor.author | Wedemeyer, H. | |
dc.contributor.author | Yurdaydin, C. | |
dc.contributor.author | Ernst, S. | |
dc.contributor.author | Caruntu, F. A. | |
dc.contributor.author | Curescu, M. G. | |
dc.contributor.author | Yalcin, K. | |
dc.contributor.author | Akarca, U. S. | |
dc.date.accessioned | 2024-04-24T16:18:49Z | |
dc.date.available | 2024-04-24T16:18:49Z | |
dc.date.issued | 2014 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description | 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver -- APR 09-13, 2014 -- London, ENGLAND | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | European Assoc Study Liver | en_US |
dc.identifier.doi | 10.1016/S0168-8278(14)60006-4 | |
dc.identifier.endpage | S3 | en_US |
dc.identifier.issn | 0168-8278 | |
dc.identifier.issn | 1600-0641 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | S2 | en_US |
dc.identifier.uri | https://doi.org/10.1016/S0168-8278(14)60006-4 | |
dc.identifier.uri | https://hdl.handle.net/11468/16292 | |
dc.identifier.volume | 60 | en_US |
dc.identifier.wos | WOS:000361961700005 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Bv | en_US |
dc.relation.ispartof | Journal of Hepatology | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keyword] | en_US |
dc.title | PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-?-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY | en_US |
dc.title | PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-?-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY | |
dc.type | Conference Object | en_US |